A clinical trial of AX 2911
Latest Information Update: 17 Mar 2025
At a glance
- Drugs AX 2911 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions
- 17 Mar 2025 New trial record
- 13 Mar 2025 According to the ProQR Therapeutics Media Release, company anticipates to initiation and topline readouts in 2026.